학술논문
1777P Enzalutamide (enza) monotherapy for the treatment (tx) of prostate cancer with high-risk biochemical recurrence (BCR): EMBARK secondary endpoints
Document Type
Abstract
Author
Source
In Annals of Oncology October 2023 34 Supplement 2:S960-S961
Subject
Language
ISSN
0923-7534